“For starters, consider Study 329, which cost GlaxoSmithKlein $3 billion for their efforts to promote antidepressants to youngsters.10 This drug company manipulated data that hid signs of increased risk of suicide. The company also falsely represented Paxil as outperforming a placebo.11”